BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2481149)

  • 1. Hepatocellular cytokeratins as substrates of transglutaminases.
    Zatloukal K; Denk H; Lackinger E; Rainer I
    Lab Invest; 1989 Dec; 61(6):603-8. PubMed ID: 2481149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linked cytokeratin polypeptides in liver and hepatoma cells: possible association with the process of cell degeneration and death.
    Fukuda K; Kojiro M; Chiu JF
    Hepatology; 1993 Jan; 17(1):118-24. PubMed ID: 7678572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
    Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
    Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay.
    Kachi K; Cadrin M; French SW
    Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
    Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
    Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody.
    Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL
    Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cytokeratins and lamins in rat liver and in rat liver cell lines as shown by immunoblotting using the monoclonal antibodies A 45-B/B3 and A 51-B/H4.
    Butschak G; Neupert G; Karsten U
    Acta Histochem Suppl; 1991; 41():107-16. PubMed ID: 1725826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pair formation and promiscuity of cytokeratins: formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides.
    Hatzfeld M; Franke WW
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1826-41. PubMed ID: 2414304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of amine acceptor protein substrates of transglutaminase in liver extracts: use of 5-(biotinamido) pentylamine as a probe.
    Ikura K; Kita K; Fujita I; Hashimoto H; Kawabata N
    Arch Biochem Biophys; 1998 Aug; 356(2):280-6. PubMed ID: 9705218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
    Zatloukal K; Böck G; Rainer I; Denk H; Weber K
    Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of transglutaminase with the reconstituted keratin filaments isolated from rat vaginal epithelial cells.
    Vijayalakshmi V; Gupta PD
    Epithelial Cell Biol; 1994; 3(4):168-74. PubMed ID: 7550609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of cytokeratin intermediate filaments by calcium-activated proteases (calpains) in vitro: implications for formation of Mallory bodies.
    Makowski GS; Ramsby ML
    Res Commun Mol Pathol Pharmacol; 1998 Sep; 101(3):211-23. PubMed ID: 9874279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver.
    Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H
    Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells.
    Quinlan RA; Cohlberg JA; Schiller DL; Hatzfeld M; Franke WW
    J Mol Biol; 1984 Sep; 178(2):365-88. PubMed ID: 6208369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemistry of cytokeratins in primary human liver tumors.
    Van Eyken P; Sciot R; Desmet VJ
    APMIS Suppl; 1991; 23():77-85. PubMed ID: 1715730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mallory body filaments become insoluble after normal assembly into intermediate filaments.
    Pollanen MS; Markiewicz P; Weyer L; Goh MC; Bergeron C
    Am J Pathol; 1994 Nov; 145(5):1140-7. PubMed ID: 7526693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover of cytokeratin polypeptides in mouse hepatocytes.
    Denk H; Lackinger E; Zatloukal K; Franke WW
    Exp Cell Res; 1987 Nov; 173(1):137-43. PubMed ID: 2445591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
    Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new amine acceptor protein substrate candidates of transglutaminase in rat liver extract: use of 5-(biotinamido) pentylamine as a probe.
    Ichikawa A; Ishizaki J; Morita M; Tanaka K; Ikura K
    Biosci Biotechnol Biochem; 2008 Apr; 72(4):1056-62. PubMed ID: 18391459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evidence that cytokeratins are present in smooth muscle.
    Turley H; Pulford KA; Gatter KC; Mason DY
    Br J Exp Pathol; 1988 Jun; 69(3):433-40. PubMed ID: 2455533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.